Released on: March 28, 2008, 4:14 am

Press Release Author: RTS Life Science

Industry:

Press Release Summary: RTS Life Science, a worldwide supplier of automated sample
management and drug delivery testing systems, today announces that it will be
unveiling its revolutionary Automated Blood Fractionation (ABF) system to the US
market for the first time at ISBER 2008,18-21 May, Bethesda, Maryland, USA. This
unique patent-pending* high throughput blood fractionation system is used to extract
buffy coat (white blood cells) from whole blood samples.

Press Release Body: RTS Life Science Unveils Revolutionary Automated Blood
Fractionation System to US Market at ISBER 2008

Manchester, UK (March 27 2008) RTS Life Science, a worldwide supplier of automated
sample management and drug delivery testing systems, today announces that it will be
unveiling its revolutionary Automated Blood Fractionation (ABF) system to the US
market for the first time at ISBER 2008,18-21 May, Bethesda, Maryland, USA. This
unique patent-pending* high throughput blood fractionation system is used to extract
buffy coat (white blood cells) from whole blood samples.

The innovative, upgradable system provides a fully automated solution to blood
fractionation and processing. The ABF system is a self-contained unit capable of
processing up to 500 samples per day, providing substantial time and labour cost
savings compared with manual fractionation. In addition, this new automated system
from RTS Life Science provides the benefits of cost and labour saving, removal of
human error, increased reproducibility and facilitation of sample tracking and
auditing.
The revolutionary ABF system incorporates unique Vision System technology which
measures the height of each fraction and calculates the volume of each layer
following fractionation via centrifugation. The ABF solution also offers significant
health and safety benefits by reducing employee exposure to unscreened blood and a
LIMS (Laboratory Information Management System) interface ensures ease of
acquisition and manipulation of data.

Kristian Spreckley, Blood Fractionation Product Manager at RTS Life Science
comments, "The key benefits to fractioning blood for biobanking are assay range and
choice. Techniques such as proteomics, metabolomics and DNA analysis, where assays
are always being developed, require efficient isolation of specific blood
components. Fractioning the blood provides you the best possible opportunity to
undertake all future analyses and essentially covers all of the bases. In addition
there is the financial impact in that blood fractionation is hugely beneficial when
building up potential DNA archives. Fractioning a sample enables the buffy coat to
be stored for future DNA extraction which means a lower preliminary investment and
negates the need to extract from samples, up to 90% of which may never be used. Our
new ABF system has been developed in response to the unique needs of the biobanking
industry and should be installed to automate blood fractionation and buffy coat
retrieval from whole blood in any high volume environment."

As well as the fully Automated Blood Fractionation System, RTS also offers this
solution as a semi-automated system. To be among the first to see this innovative
new offering from RTS Life Science please visit ISBER 2008, 18-21 May, Bethesda,
Maryland, USA.
More information about RTS Life Science is available at www.rtslifescience.com or by
e-mail lifescience.info@rts-group.com.

*Patent Application Number 0422358.2
About RTS Life Science:

RTS Life Science is a UK-based supplier of drug discovery and drug delivery
automation solutions for large scale sample management and high throughput testing
in laboratories. RTS Life Science is owned by Robotic Technology Systems PLC, an
AIM-listed company.

For further press information please contact: Sophie Downend, The Scott Partnership,
1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA United Kingdom Tel: +
44 1477 539539 Fax: +44 1477 539540 e-mail to: rts@scottpr.com

Web Site: http://

Contact Details: THE SCOTT PARTNERSHIP
1 WHITESIDE
STATION ROAD
HOLMES CHAPEL
CHESHIRE
CW4 8AA
01477 539539
rts@scottpr.com